Update from the UK Pharmacy Professional Leadership Advisory Board – December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board

The UK Pharmacy Professional Leadership Advisory Board met for the fourth time on 10 December 2024. Through the Board’s work, closer collaboration between pharmacy professional leadership bodies and specialist professional groups, supported by Independent Expert Members, will enable and support pharmacists and pharmacy technicians to meet the opportunities and challenges ahead.

Following another positive and productive meeting, the Board has published:

-A statement

-A blog post

-Minutes of the September 2024 meeting

-A draft Vision and Common Purpose for Pharmacy Professional Leadership (Also added to the BOPA website here: A Vision and Common Purpose for the future of UK Pharmacy Professional Leadership – BOPA


To read these and more information about the Board’s work, please visit Independent UK Pharmacy Professional Leadership Advisory Board to strengthen collaboration | Join the Conversation (scwcsu.nhs.uk).

You can also follow the Board on X: https://twitter.com/ukpplboard and on LinkedIn.  

Best regards.

UK Pharmacy Professional Leadership Advisory Board Secretariat

Email: [email protected]


A Vision and Common Purpose for the future of UK Pharmacy Professional Leadership – BOPA

Latest News

By BOPA Committee on 22nd January 2025

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications is now open. For more info click here and/or see flyer below.  

Read article
By BOPA research committee on 22nd January 2025

SURVEY: Examining barriers to pharmacy professionals engaging with research

The Incubator for Pharmacy Professionals is an NIHR-supported initiative dedicated to strengthening research capacity within the pharmacy profession. Despite its critical role as a pillar of professional practice, research remains…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA Committee on 20th January 2025

UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…

Read article